Interview with Victor Ferkovich, Country Manager, Celgene Russia
Celegene did not have a Russian affiliate office during Focus Reports’ initial report on Russia in 2006. What…
Celgene Russia
Last updated: 13.02.2014
Address: 1st Tverskaya-Yamskaya st., 21 Business Centre ‘Four Winds Plaza’ 125047, Moscow,Russia
Tel: +7 495 777 6 555
Company description
Committed to Improving the Lives of Patients Worldwide
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.
As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
Celgene in Russia
Celgene Russia was established as an entity in 2008. It actively engages in Russian clinical trials, and marketing and product promotion. It aims to establish market leadership in indications that are in line with Celgene’s global strategy, as well as develop a strong presence in state reimburesement programs.
Products and services
Drug therapies for cancer and inflammatory disorders.
Interviews
Related
Russia / Biocad Ramps up Sputnik V Manufacturing; Unlicensed Remdesivir Generics; Chinese Vaccine Rejection
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
Russia / $7.4 bln for Healthcare Modernisation; Generics Push; Sputnik Vaccine Successes
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
COVID-19 / Russia First Mover in Approving Vaccine Amid Widespread Criticism
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities,…
News Roundup / Russian Pharma: April 2020
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in…
Drug Shortages / An Increasing Concern in Russia
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening…
Russian bots targeted US and vaccines
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has…
Interview with Arman Voskertchyan, Managing Director, Johnson & Johnson…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this…
Interview with Eric Blondeau, Managing Director, Alliance Healthcare Russia
You took over this organization just three months ago, having previously headed businesses in industries as diverse…
Interview with Victor Dmitriev, General Director, Association of the Russian…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the…
Interview with Vladimir Shipkov, Executive Director, Association of…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of…
Interview with Andrew Somers, President & CEO, American Chamber of Commerce…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of…
Interview with Svetlana Zavidova, Executive Director, Association of Clinical…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the…
